Antibiotics optimization and the burden of carrying a penicillin allergy label Most medicines remain effective for prolonged periods, even when used by many people. Antibiotics are a critical exception: Antimicrobial resistance (AMR) diminishes their effectiveness over time. Since the discovery of penicillin in 1928, medicine has made tremendous advances, but very few new antibiotics have been developed. The World Health Organization (WHO) warned in 2017 that new antibiotic development is insufficient to keep pace with rising resistance. To guide safe and effective antibiotic use, the WHO developed the AWaRe antibiotic categorization. In this system, beta-lactam antibiotics – including penicillins – are identified as “first-choice” options because they offer the best balance of effectiveness, safety, and minimal resistance risk.1 Unfortunately, the impact of these antibiotics has been undermined by inaccurate allergy labels to penicillin and related drugs such as amoxicillin and amoxicillin-clavulanic acid. These erroneous labels often prevent optimal antibiotic use and contribute to the growing resistance problem.2 In a recent study conducted at Tufts University and the Massachusetts Department of Public Health, researchers found that in 20 LTC facilities across the state, an estimated 50% to 75% of LTC residents received an antibiotic annually, with a 34.7% documented prevalence of penicillin allergy recorded in LTC.3 ALK’s Antimicrobial stewardship mission 1. Raise awareness on the critical impact of penicillin allergy labels on infectious disease and ever rising healthcare costs. 2. Facilitate accurate correction. We invite all branches of the health system to join us and optimize antibiotics use, assuring only those with a true penicillin allergy carry the label and are empowered to manage their care appropriately. Attention Ontario Long-Term Care Homes FREE Penicillin Allergy Re-evaluation Clinics Available This Fall Unlock first line antibiotics options for your residents – at no cost to your facility This is a collaborative improvement initiative with trusted clinical partners. Limited number of spots are available. Reach out today! For more information or to express interest, please contact: Doris Djantio / Diagnostics Manager & AMS lead, ALK Canada / Tel.: 1 437 684 1141 | Email: doris.djantio@alk.net The benefits of reclassifying patients as non-allergic are well documented. 21% (p=.008) decrease in 30-day hospital readmission rate.5 In a retrospective study in 2 tertiary care hospitals over almost 6 years, patients without a penicillin allergy had a 15.1% 30-day readmission rate compared with 19.2% for patients with penicillin allergies.5 Nearly 35% (p<.001) decreased risk of infection with Clostridioides difficile (C.diff).6 27% (p=.03) lower rate of clinical failure.7 Additionally, patients with a reported allergy had a 50% increased risk of developing a surgical site infection (p=.04).8 Demonstrated decreases in MRSA and VRE have also been seen in patients without penicillin allergies.8,9 1. World Health Organization. WHO AWaRe System for Antimicrobial Stewardship. Who.int. Published 2026. Accessed September 2, 2026. https://www.who.int/teams/surveillance-prevention-control-AMR/control-and-response-strategies/AWaRe. 2. Collins C. The low risks and high rewards of penicillin allergy de-labeling: an algorithm to expedite the evaluation. J Pediatr. 2019;212:216- 223. doi:10.1016/j.jpeds. 3. Foong KS, Doron SI, Fowle L, et al. Documented penicillin allergy and beta-lactam antibiotic use in Massachusetts long-term care facilities: opportunities for penicillin allergy de-labeling. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e166. doi:10.1017/ash.2024.434 4. Centers for Disease Control and Prevention. Clinical features of penicillin allergy. cdc.gov. Published August 25, 2025. Accessed September 10, 2026. https://www.cdc.gov/antibiotic-use/hcp/clinical-signs/index.html. 5. Huang KH, Cluzet V, Hamilton K, Fadugba O. The impact of reported beta-lactam allergy in hospitalized patients with he-matologic malignancies requiring antibiotics. Clin Infect Dis. 2018;67(1):27-33. doi :10.1093/cid/ciy037 6. Centers for Disease Control and Prevention. Core Elements of hospital antibiotic stewardship. cdc.gov. Published September 15, 2025. Accessed September 10, 2026. https://www.cdc.gov/antibiotic-use/media/pdfs/hospital-core-elements-508.pdf. 7. Jeffres MN, Narayanan PP, Shuster JE, Schramm GE. Consequences of avoiding _-lactams in patients with _-lactam allergies. J Allergy Clin Immunol. 2016;137(4):1148-1153. doi:10.1016/j.jaci.2015.10.026 8. Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES. The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis. 2018;66(3):329-336. doi:10.1093/cid/cix794 9. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133(3):790-796. doi:10.1016/j.jaci.2013.09.021 By removing the “penicillin allergic” label from your nonallergic patients CHANGE THEIR THERAPY. IMPROVE THEIR OUTCOMES. Many patients outgrow their penicillin allergy Lose their sensitivity after 10 years4 80%
View this content as a flipbook by clicking here.